Lara Meisner, Chief Legal Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 12,626 shares at $25.02 ($314K) on 2023-06-06, disclosed to the SEC on 2023-06-06.
Scheduled sale ($314k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.21 | 1,875 | $45K | 14.4% |
| 2 | $25.03 | 499 | $12K | 4.0% |
| 3 | $25.02 | 5,126 | $128K | 40.8% |
| 4 | $25.02 | 5,126 | $128K | 40.8% |
| Total | $24.90 avg | 12,626 | $314K | 100% |
| Filing → |
| BCAX | SELL | 2025-06-18 | $330K | — | Filing → |
| BCAX | SELL | 2025-03-18 | $2.0M | — | Filing → |
| VRDN | SELL | 2023-06-20 | $128K | — | Filing → |